ReviewBJUI compass2026

Addition of immune checkpoint inhibitors to intravesical BCG for high-risk BCG-naïve non-muscle invasive bladder cancer: Systematic review and meta-analysis.

Renil S Titus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.